Eisai 2012 First Quarter Aricept Sales Down 20%
This article was originally published in PharmAsia News
Executive Summary
Eisai announced first quarter results August 1, and domestic sales of the company’s flagship Alzheimer drug Aricept, launched in November 2011 as a generic drug, decreased by 23.9% as prices of the drug decreased by 16%.